Modified vincristine, doxorubicin, and dexamethasone regimen in the treatment of resistant or relapsed chronic lymphocytic leukemia an eastern cooperative oncology group study
- 15 May 1993
- Vol. 71 (10) , 2983-2989
- https://doi.org/10.1002/1097-0142(19930515)71:10<2983::aid-cncr2820711016>3.0.co;2-1
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- B-cell chronic lymphocytic leukemia: present status and future directions. French Cooperative Group on CLLBlood, 1991
- Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia.Journal of Clinical Oncology, 1991
- Fludarabine phosphate: a synthetic purine antimetabolite with significant activity against lymphoid malignancies.Journal of Clinical Oncology, 1991
- Current approaches to the chemotherapy of B-cell chronic lymphocytic leukemia: A reviewAmerican Journal of Hematology, 1989
- Fludarabine: a new agent with major activity against chronic lymphocytic leukemiaBlood, 1989
- Pentostatin in chronic lymphocytic leukemia: a phase II trial of Cancer and Leukemia group B.Journal of Clinical Oncology, 1989
- 2-Chlorodeoxyadenosine: an effective new agent for the treatment of chronic lymphocytic leukemiaBlood, 1988
- Therapy of lymphoid and undifferentiated chronic myelogenous leukemia in blast crisis with continuous vincristine and adriamycin infusions plus high-dose decadronCancer, 1987
- The treatment of chronic lymphocytic leukemia with COP chemotherapyCancer, 1978
- Vincristine therapy of lymphomas and chronic lymphocytic leukemiaCancer, 1970